Diebold Nixdorf
DBD
$84.51
+5.89%
DBD price trend
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Diebold Nixdorf's 12-month outlook, with a consensus price target around $109.86 and implied upside of +30.0% versus the current price.
Average Target
$109.86
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$68 - $110
Analyst target range
DBD Technical Analysis
Beta
1.48
1.48x market volatility
Max Drawdown
-17.7%
Largest decline past year
52-Week Range
$36-$85
Price range past year
Annual Return
+104.1%
Cumulative gain past year
| Period | DBD Return | S&P 500 |
|---|---|---|
| 1m | +12.2% | +0.4% |
| 3m | +25.4% | -2.0% |
| 6m | +53.9% | +4.1% |
| 1y | +104.1% | +23.9% |
| ytd | +32.1% | -0.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Valuation Analysis: Is DBD Overvalued?
PE
26.4x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
8.9x
Enterprise Value Multiple
